Rankings
▼
Calendar
MDGL Q2 2016 Earnings — Madrigal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
MDGL
Madrigal Pharmaceuticals, Inc.
$10B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-16.33
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$545,000
Balance Sheet
Total Assets
$45M
Total Liabilities
$3M
Stockholders' Equity
$42M
Cash & Equivalents
$11M
← FY 2016
All Quarters
Q3 2016 →
